Successful treatment of a case of relapsed acute promyelocytic leukemia with arsenic trioxide

被引：1

作者：

Hirayama, Y ^{[1
]}

Koyama, R ^{[1
]}

Nagai, T ^{[1
]}

Ohta, H ^{[1
]}

Kondo, A ^{[1
]}

Ishikawa, K ^{[1
]}

Ishitani, K ^{[1
]}

Matsunaga, T ^{[1
]}

Sakamaki, S ^{[1
]}

Niitsu, Y ^{[1
]}

机构：

[1] Hokkaido Prefectural Sapporo Kitano Hosp, Sapporo, Hokkaido, Japan

来源：

INTERNAL MEDICINE | 2001年 / 40卷 / 11期

关键词：

ATRA; skin erythema; neuralgia;

D O I：

10.2169/internalmedicine.40.1136

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We report a patient with an initial relapse of acute promyelocytic leukemia (APL) who achieved a second complete remission (CR) after treatment with arsenic trioxide. The patient, a 66-year-old woman diagnosed as having relapsed APL, received arsenic trioxide intravenously at a dose of 10 mg/day. At day 36, the patient achieved a second CR. The side effects were slight neuralgia and mild skin erythematous changes, which improved following cessation of the drug. Although arsenic trioxide may be effective for relapsed APL, it should be used with caution because of various complications.

引用

页码：1136 / 1139

页数：4

共 50 条

[21] Oral arsenic trioxide for relapsed acute promyelocytic leukemia in pediatric patients
Au, Wing Y.
Li, Chi-Kong
Lee, Vincent
Yuen, Hui Leung
Yau, Jeffrey
Chan, Godfrey C. F.
Ha, Shau-yin
Kwong, Yok-lam
PEDIATRIC BLOOD & CANCER, 2012, 58 (04) : 630 - 632
[22] Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: a bridge to transplantation
Leoni, F
Gianfaldoni, G
Annunziata, M
Fanci, R
Ciolli, S
Nozzoli, C
Ferrara, F
HAEMATOLOGICA, 2002, 87 (05) : 485 - 489
[23] Arsenic trioxide in the treatment of advanced acute promyelocytic leukemia
Carmosino, I
Latagliata, R
Avvisati, G
Breccia, M
Finolezzi, E
Lo Coco, F
Petti, MC
HAEMATOLOGICA, 2004, 89 (05) : 615 - 617
[24] Treatment of acute promyelocytic leukemia with arsenic trioxide - Reply
Warrell, RP
Pandolfi, PP
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (13): : 1044 - 1045
[25] Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia
Lengfelder, E.
Hofmann, W-K
Nowak, D.
LEUKEMIA, 2012, 26 (03) : 433 - 442
[26] Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia
E Lengfelder
W-K Hofmann
D Nowak
Leukemia, 2012, 26 : 433 - 442
[27] Successful Treatment With ATRA and Arsenic Trioxide for a Child With Down Syndrome and Acute Promyelocytic Leukemia
Tsumura, Yusuke
Yamada, Yuji
Osumi, Tomoo
Kato, Motohiro
Terashima, Keita
Shioda, Yoko
Kiyotani, Chikako
Matsumoto, Kimikazu
Tomizawa, Daisuke
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (04) : 322 - 325
[28] Successful pregnancy after arsenic trioxide therapy for relapsed acute promyelocytic leukaemia
Ammatuna, Emanuele
Cavaliere, Annafranca
Divona, Mariadomenica
Amadori, Sergio
Scambia, Giovanni
Lo-Coco, Francesco
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (03) : 341 - 341
[29] Treatment of Relapsed Acute Promyelocytic Leukemia with Oral Arsenic Trioxide: An Eleven-Year Experience
Au, Wing-Yan
Tam, Sidney
Leung, Anskar Y. H.
Tse, Eric
Kumana, Cyrus
Kwong, Yok Lam
BLOOD, 2008, 112 (11) : 1016 - 1016
[30] Cost-Effectiveness Of Arsenic Trioxide In The Treatment Of Relapsed/Refractory Acute Promyelocytic Leukemia In Canada
Lachaine, Jean
Mathurin, Karine
Barakat, Stephane
BLOOD, 2013, 122 (21)

← 1 2 3 4 5 →